875271-89-9

Upstream product

• 875271-72-0 [2-Phenyl-5-(2-phenyl-1H-indole-6-carbonyl)thiophene-3-yl]acetic acid 
• 31938-11-1 O-tritylhydroxylamine 
• 875271-79-7 (2-phenylthiophen-3-yl)acetic acid methyl ester 
• 875271-86-6 (2-phenylthiophen-3-yl)acetic acid ethyl ester 
• 136343-83-4 (E)-4-Chloro-3-formyl-4-phenyl-but-3-enoic acid ethyl ester 
• 6270-17-3 ethyl 3-benzoylpropanoate 
• 62404-09-5 2-Phenyl-3-thienylacetic acid 
• 875271-88-8 {5-[3-amino-4-(phenylethynyl)benzoyl]-2-phenylthiophene-3-yl}acetic acid methyl ester 
• 875271-85-5 [2-phenyl-5-(2-phenyl-1H-indole-6-carbonyl)thiophene-3-yl]acetic acid methyl ester 
• 875271-84-4 [5-(3-amino-4-iodo-benzoyl)-2-phenyl-thiophen-3-yl]-acetic acid methyl ester 
• 875271-83-3 [5-(4-iodo-3-nitro-benzoyl)-2-phenyl-thiophen-3-yl]-acetic acid methyl ester 

Relevant academic research and scientific papers

SMALL-MOLECULE BOTULINUM TOXIN INHIBITORS

Small-molecule inhibitors of Botulinum toxin, including BoNTA, BoNTD and BoNTE are provided, as well as methods of using the inhibitors.

Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A

Botulinum neurotoxin serotype A (BoNTA) is one of the most toxic substances known. Currently, there is no antidote to BoNTA. Small molecules identified from high-throughput screening reportedly inhibit the endopeptidase-the zinc-bound, catalytic domain of